Bliss GVS Pharma Ltd Quarterly Results

Gross Sales

210.42

217.68

183.64

198.13

200.72

Excise Duty

0

0

0

0

0

Net Sales

210.42

217.68

183.64

198.13

200.72

Other Operating Income

0

0

0

0

0

Other Income

15.27

5.04

4.12

5.6

5.42

Total Income

225.68

222.72

187.77

203.73

206.14

Total Expenditure

180.63

176.2

149.31

198.98

157.02

PBIDT

45.05

46.51

38.45

4.75

49.12

Interest

1.08

3.83

1.53

1.85

2.12

PBDT

43.97

42.69

36.92

2.9

47

Depreciation

7.55

6.98

6.85

6.85

6.95

Minority Interest Before NP

0

0

0

0

0

Tax

13.76

11.09

8.63

8.43

7.75

Deferred Tax

-3.14

-1.08

-0.67

-7.47

3.22

Reported Profit After Tax

25.8

25.69

22.11

-4.91

29.07

Minority Interest After NP

2

1.43

1.41

4.23

1.46

Net Profit after Minority Interest

23.8

24.26

20.7

-9.15

27.61

Extra-ordinary Items

0

0

0

-20.76

0

Adjusted Profit After Extra-ordinary item

23.8

24.26

20.7

11.61

27.61

EPS (Unit Curr.)

2.27

2.31

1.97

-0.88

2.64

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.54

10.51

10.49

10.47

10.47

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.4

21.36

20.93

2.39

24.47

PBDTM(%)

20.89

19.61

20.1

1.46

23.41

PATM(%)

12.26

11.8

12.03

-2.47

14.48